Mumbai: Sun Pharmaceutical Industries Limited and Philogen S.p.A. have announced the successful completion of patient ...

Uday Kotak and family buy 12 flats at Worli Seaface for ₹201.89 crore, setting a new Mumbai real estate record of ₹2.72 lakh per sq ft.

Aalok Shanghvi completed his graduation in Cellular and Molecular Biology from the University of Michigan, US.

Aalok is the son of Dilip Shanghvi, chairman and managing director of Sun Pharma. Aalok's father is India's richest pharma ...

The next generation has been entrusted with more responsibility at the family-run Sun Pharma, India’s largest drug maker, and ...

Sun Pharma has promoted Aalok Shanghvi to Chief Operating Officer. Previously a Whole-time Director, Shanghvi has been with the company since 2006. Known for his diverse role experience, he has ...

Sun Pharmaceutical Industries has elevated Aalok Shanghvi, son of MD Dilip Shanghvi, as its new Chief Operating Officer.

Sun Pharma, India’s pharmaceutical giant, has elevated Aalok Shanghvi, the son of Dilip Shanghvi, chairman and managing ...

Sun Pharma appoints Aalok Shanghvi as COO, overseeing global operations and R&D, with expertise in emerging markets.

Sun Pharmaceutical Industries reported a 15 percent on-year increase in consolidated net profit, reaching Rs 2,903 crore for ...

Sun Pharma reported a 15% YoY rise in Q3FY25 profit to Rs 2,903 crore, surpassing estimates. Revenue grew 10% to Rs 13,675.5 crore, driven by domestic and emerging markets. API sales rose 22%, while ...